Edition:
India

Suven Life Sciences Ltd (SUVP.NS)

SUVP.NS on National Stock Exchange of India

37.80INR
3:59pm IST
Change (% chg)

Rs-0.95 (-2.45%)
Prev Close
Rs38.75
Open
Rs39.40
Day's High
Rs39.40
Day's Low
Rs37.50
Volume
301,521
Avg. Vol
743,982
52-wk High
Rs334.70
52-wk Low
Rs15.20

Latest Key Developments (Source: Significant Developments)

Suven Life Sciences Gets Tribunal Nod For Scheme Of Arrangement
Tuesday, 7 Jan 2020 

Jan 7 (Reuters) - Suven Life Sciences Ltd ::NCLT BENCH PASSED ORDER ORDER ALLOWING COMPANY PETITION FILED FOR SANCTION OF COMPOSITE SCHEME OF ARRANGEMENT.SCHEME AMONGST SUVEN LIFE SCIENCES LIMITED AND SUVEN PHARMACEUTICALS LIMITED.  Full Article

Suven Life Sciences Ltd Receives EIR From U.S. FDA For Pashamylaram Facility
Thursday, 19 Dec 2019 

Dec 19 (Reuters) - Suven Life Sciences Ltd ::SUVEN LIFE SCIENCES LTD SAYS RECEIVES EIR FROM US FDA FOR ITS PASHAMYLARAM FACILITY.SUVEN LIFE SCIENCES LTD SAYS FDA HAS DETERMINED THAT INSPECTION CLASSIFICATION OF THIS FACILITY IS "VOLUNTARY ACTION INDICATED".  Full Article

India's Suven Life Sciences Sept-Quarter Profit Rises
Thursday, 14 Nov 2019 

Nov 14 (Reuters) - Suven Life Sciences Ltd ::SEPT-QUARTER CONSOL NET PROFIT 633.1 MILLION RUPEES VERSUS 38.7 MILLION RUPEES YEAR AGO.SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 2.74 BILLION RUPEES VERSUS 895.2 MILLION RUPEES YEAR AGO.  Full Article

India's Suven Life Sciences Dec-Qtr Net Profit Falls
Tuesday, 5 Feb 2019 

Feb 5 (Reuters) - Suven Life Sciences Ltd ::DEC QUARTER NET PROFIT 252.3 MILLION RUPEES VERSUS PROFIT 346 MILLION RUPEES YEAR AGO.DECLARED INTERIM DIVIDEND OF 1.50 RUPEES PER SHARE.DEC QUARTER REVENUE FROM OPERATIONS 1.29 BILLION RUPEES VERSUS 1.64 BILLION RUPEES YEAR AGO.  Full Article

BRIEF-Suven Pharmaceuticals March Quarter Consol Profit Falls

* SUVEN PHARMACEUTICALS - MARCH QUARTER CONSOL NET PROFIT 741.8 MILLION RUPEES VERSUS 748.2 MILLION RUPEES